Shanna L. Ashley

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
RATIONALE Biomarkers in easily accessible compartments like peripheral blood that can predict disease progression in idiopathic pulmonary fibrosis (IPF) would be clinically useful regarding clinical trial participation or treatment decisions for patients. In this study, we used unbiased proteomics to identify relevant disease progression biomarkers in IPF.(More)
  • 1